Abstract
Changes in legislation and case law have brought about several changes in the way that doctors in England and Wales have to deal with consent and capacity issues. These changes affect dermatology in many ways regarding the way we gain consent and the information we have to share with the patient. This article will provide an update and overview on these changes and how they affect dermatology in particular. Legislation changes have opened up avenues to discuss difficult advance decisions with patients. It is hoped that these will reduce the number of ethical dilemmas arising from questions about the treatment of incapacitated patients. It is also necessary, following recent case law, to document and discuss any significant, unavoidable or frequently occurring side-effects of any proposed medication with patients. This means that the recent changes in legislation and case law bring opportunities to dermatologists, but also require improved documentation.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
